Introduction
Thyrotoxicosis is a well recognized cause of atrial dysrhythmias but frequently the endocrine component may not be clinically evident (Symons, Richardson and Wood, 1971) ; thus, a remediable cause of cardiac disability may go unrecognized. The results are now reported of screening a group of euthyroid patients with cardiac disorder, using thyroid function tests including the thyroidstimulating hormone (TSH) response to thyrotrophin releasing hormone (TRH) (Ormston et al., 1971; Birk Lauridsen et al., 1974) .
Patients and methods
Three groups of clinically euthyroid patients were studied over a period of approximately 2 years. The first group comprised fifty patients who were known to have had atrial fibrillation for at least one year before this study. There were fourteen with rheumatic heart disease, six with ischaemia due to coronary artery disease and thirty with idiopathic atrial fibrillation. In those with idiopathic fibrillation, although the dysrhythmia was probably due to some form of cardiac ischaemia, there was no symptomatic or electrocardiographic evidence of coronary disease. The second group of twenty-eight patients were known to have had at least one proved attack of atrial dysrhythmia (atrial fibrillation, flutter or tachycardia); there were two with rheumatic heart disease, five with ischaemia due to coronary disease, and twenty-one with idiopathic atrial fibrillation without evidence of coronary artery disease. The third group of sixty-three patients were in sinus rhythm without history of dysrhythmia (initially conceived as a control series) but who had long-standing coronary artery disease. No one with acute cardiac ischaemia was studied. (Gordin et al., 1974; Gordin and Lamberg, 1975) .
3. In patients with abnormal TSH/TRH results, both thyroglobulin and microsomal antibody titres were measured by haemagglutination techniques (Bird and Stephenson, 1973; Perrin and Bubel, 1974) . They were also measured in a representative number (ninety-six cases) of other patients from all groups with normal TSH/TRH tests. Titres in excess of 1 :1000 were considered significant for microsomal antibodies and 1 : 100 for thyroglobulin antibodies.
4. Serum cholesterol levels (normal 3 5-6 5 mmol/l).
Results
The TSH/TRH test and antibody results are shown in Table 2 and T4 levels in Table 3 . In group 1, forty-one patients including four abnormal responders had basal TSH levels of < 5 ,uu./ml; of the nine patients who had basal TSH levels of > 5 ,iu./ml, eight were abnormal responders.
Four of the patients with abnormal TRH tests had positive antibodies. All the abnormal responders were female. Two were found to be hyperthyroid (TSH levels < 1 0 l,u./ml basally, 20 and 60 min after TRH, serum T4 >200 nmol/l, thyroid antibodies positive in both cases).
In group 2, twenty-five patients including one abnormal responder had basal TSH levels < 5 tju./ml; three patients, all of whom were abnormal responders, had basal TSH levels >5 ,Lu./ml. One of the four abnormal responders had positive antibodies. All the abnormal responders were female. One patient was found to be hyperthyroid; TSH levels were 10 ,uu./ml basally, 20 and 60 min after TRH, serum thyroxine >200 nmol/l and thyroid antibodies positive.
In (Tunbridge, Harsoults and Goolden, 1974; Toft et al., 1974) auto-immune thyroiditis (Gordin et al., 1974; Gordin and Lamberg, 1975) exophthalmos (Chopra et al., 1974; Franco et al., 1973) and malnutrition (Pimstone, Becker and Hendricks, 1973) . The reason for the raised TSH levels in these cases is unknown but it has been suggested that excessive pituitary drive on the normal remaining thyroid gland is required to maintain an euthyroid status (Tunbridge et al., 1974) . The authors have been unable to find any reported study of the frequency of occurrence of abnormal TSH/TRH tests in normal or euthyroid subjects. The only value for TSH in a general population is a basal figure reported by the Whickham Survey Group where 2 8% of males and 7.505 of females had TSH levels of greater than 6 ,uu./ml (Tunbridge, 1976) . But a single TSH estimation is of limited use, because, of the abnormal responders in the present report, seven had initial levels of less than 6-0 ,uu./m1, i.e. the complete TSH/ TRH test must be employed if its full value is to be realized, and this is also the view of AlaghbandZadeh et al. (1977) . The percentage of patients with positive thyroid antibodies in the three groups (20, 28, 18% respectively), albeit in a hospital population, is also higher than expected. In a mixed hospital and volunteer group of middle-aged women, Mittra, Perrin and Kumaoka (1976) found antibodies in 26%, but their lower limits of titres were less than the present series, namely 1: 20 for thyroglobulin and 1: 100 for microsomal antibodies. In contrast, the Whickham Survey found that in a general population microsomal antibodies were present in 2-7 males and 10-3% females with lower figures for thyroglobulin antibodies (Tunbridge, 1976; Tunbridge et al., 1976) . Over a third of the present cases who responded abnormally to TRH had positive antibodies. The difference between the proportion of abnormal TSH/TRH responders and normal responders who have positive antibodies, shown in Table 2 , suggests that the abnormally responding patients have some form of thyroid auto-immune disease, although the numbers for comparison are too small to be significant.
Of the twelve patients who had atrial dysrhythmias and an exaggerated TRH response, three presented with fast atrial fibrillation more in keeping with hyperthyroidism than depressed thyroid reserve or hypothyroidism (where in any case atrial fibrillation is an unusual finding). In the majority of patients, the ventricular response was adequately controlled by digoxin, occasionally with propranolol, but in two cases this had only minimal effect and carbimazole was given. There was no improvement and the serum TSH increased. A cautious trial of triiodothyronine was instituted with little clinical response but the serum TSH fell to the lowest level of normal, thus demonstrating the integrity of the hypothalamic--pituitary axis. The duration of the ankle tendon reflex was not prolonged in any of the twenty-two patients who responded abnormally to TRH. It was not possible to differentiate clinically between patients with an abnormal or normal TSH/TRH response. To date, follow-up observation of the abnormal TRH responders has not disclosed any progression to obvious hypothyroidism.
A normal serum thyroxine, raised TSH levels and positive thyroid antibodies is suggestive of preclinical hypothyroidism or low thyroid reserve. Although the latter may account for the abnormal findings it does not explain why in many instances the presentation with tachycardia and atrial fibrillation should be so unlike the picture of thyroid insufficiency, or why the number of cardiac patients with abnormal tests should be so high. Bastenie, Vanhaelst and Neve (1967) and Fowler, Swale and Andrews (1970) have suggested an association between thyroid and ischaemic heart disease and Tunbridge et al. (1976) have hinted of this in females.
The present data do not entirely support this view for although the authors found a high incidence of abnormal TSH/TRH tests in the ischaemic group, owing to coronary artery disease, the percentage of patients with abnormal TSH/TRH tests was greater in the dysrhythmia groups where ischaemia from coronary disease was less prevalent. Also, the serum cholesterol levels did not differ in any of the groups. Atrial muscle disease has been reported in thyrotoxicosis (Wan, Lee and Toh, 1972) and Fairfax and Leatham (1975) have described patients with idiopathic heart block who had thyroid or other auto-immune disorders. As has been suggested by Mathews, Whittingham and Mackay (1974) , the auto-immune process itself may be invoked as a cause of vascular disease and the action on the cardiovascular system of circulating immune complexes in thyroid disease and even of the metabolic effects of high concentration of TSH needs to be explored (Bastenie et al., 1977) . The present authors suggest that the problem is much wider than that of a correlation simply between symptomless autoimmune thyroiditis and coronary disease and that other types of heart disease especially with atrial dysrhythmia may be produced or aggravated by auto-immune processes.
The authors cannot explain why a high proportion of their patients have positive thyroid antibodies but there is a hypothesis which can account for their other findings. Thyroid auto-immune disease, present in a large number of their cases, might result in the abnormal breakdown of thyroxine with the formation of analogues of thyroxine (Braverman, Ingbar and Sterling, 1970) , namely triac or tetrac. This would explain the euthyroid state (for these compounds have a weak metabolic action [Lerman and Pitt-Rivers, 1956] ), the partial suppression of thyroid activity with a consequent rise in TSH and also a specific effect on the heart. Triac has a specific and profound action on heart muscle in that experimentally it increases cardiac cellular oxygen requirements (Barker and Lewis, 1956 ) and alters fibre morphology (Symons, Olsen and Hawkey, 1975; Olsen, Symons and Hawkey, 1977) . The presence of triac and tetrac in the serum of a patient with thyrocardiac disorder has been reported previously (Symons, Richardson and Wood, 1971) and the measurement of circulating analogues of thyroxine in patients with auto-immune thyroid disease and cardiac disorders is required.
